Noxopharm Annual Report 2022

Annual Report 2022 57 Shareholder Information The shareholder information set out below was applicable as at 17 August 2022 NOX ordinary shares Number of holders % by number of holders Total number of shares % by number of shares issued 1 to 1,000 427 10.43% 243,506 0.08% 1,001 to 5,000 1,127 27.53% 3,166,940 1.08% 5,001 to 10,0000 694 16.96% 5,607,694 1.92% 10,0001 to 100,000 1,469 35.89% 52,597,974 18.00% 100,001 and above 376 9.17% 230,621,836 78.92% 4,093 292,237,950 NOXO - (listed options at $0.30, expiry 18 June 2023) Number of holders % by number of holders Total number of options % by number of options issued 1 to 1,000 239 27.99% 102,713 0.51% 1,001 to 5,000 299 35.01% 708,174 3.54% 5,001 to 10,000 107 12.53% 764,281 3.82% 10,001 to 100,000 173 20.26% 5,512,217 27.53% 100,001 and above 36 4.22% 12,934,948 64.60% 854 20,022,333 NOXOA - (listed options at $0.315 expiry 14 Aug 2023) Number of holders % by number of holders Total number of options % by number of options issued 1 to 1,000 3 2.44% 1,606 0.01% 1,001 to 5,000 11 8.94% 24,124 0.11% 5,001 to 10,000 9 7.32% 66,120 0.31% 10,001 to 100,000 58 47.15% 2,751,328 12.92% 100,001 and above 42 34.15% 18,460,071 86.65% 123 21,303,249

RkJQdWJsaXNoZXIy MjE2NDg3